Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs

AIDS. 2000 Dec 22;14(18):2943-5. doi: 10.1097/00002030-200012220-00019.

Authors

N Yahi¹, C Tourrès, N Tivoli, P Colson, C Dhiver, A M Quinson, C Tamalet

Affiliation

¹ Laboratoire de Virologie, UF SIDA, CHRU La Timone, France.

PMID: 11153678
DOI: 10.1097/00002030-200012220-00019

No abstract available

MeSH terms

Anti-HIV Agents / pharmacology*
Anti-HIV Agents / therapeutic use
Drug Administration Schedule
Drug Resistance, Microbial / genetics
Drug Resistance, Multiple / genetics
Drug Therapy, Combination
Evolution, Molecular*
Genotype
HIV Infections / drug therapy
HIV Infections / virology*
HIV Reverse Transcriptase / genetics
HIV-1 / drug effects*
HIV-1 / genetics
Humans
Mutation
Reverse Transcriptase Inhibitors / pharmacology*
Reverse Transcriptase Inhibitors / therapeutic use

Substances

Anti-HIV Agents
Reverse Transcriptase Inhibitors
HIV Reverse Transcriptase